What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Year 2017 Referencia Eur Stroke J. 2017 Sep;2(3):229-237. doi: 10.1177/2396987317704547. Epub 2017 Apr 19. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1177/2396987317704547 Revista European stroke journal Títol Complet GISCOME - Genetics of Ischaemic Stroke Functional Outcome network: A protocol for an international multicentre genetic association study. Codi 51252 PMID https://pubmed.ncbi.nlm.nih.gov/31008316 Nom Autors Bevan, Steve; Fernandez-Cadenas, Israel; Hankey, Graeme J; Jern, Christina; Jimenez-Conde, Jordi; Jood, Katarina; Lee, Jin-Moo; Lemmens, Robin; Levi, Christopher; Lindgren, Arne et al. DOI número 10.1177/2396987317704547 Year 2017 Referencia Br J Cancer. 2017 Oct 24;117(9):1278-1285. doi: 10.1038/bjc.2017.290. Epub 2017 Aug 29. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/bjc.2017.290 Revista BRITISH JOURNAL OF CANCER Títol Complet Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib. Codi 51251 PMID https://pubmed.ncbi.nlm.nih.gov/28850565 Nom Autors Adenis, Antoine; Barone, Carlo; Bauer, Sebastian; Blay, Jean-Yves; Bouche, Olivier; Camozzi, Maura; Castellana, Ramon; Comandone, Alessandro; Crippa, Stefania; Del Muro, Xavier Garcia et al. DOI número 10.1038/bjc.2017.290 Year 2017 Referencia Mol Genet Metab. 2017 Nov;122(3):122-129. doi: 10.1016/j.ymgme.2017.08.002. Epub 2017 Aug 4. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.ymgme.2017.08.002 Revista MOLECULAR GENETICS AND METABOLISM Títol Complet Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians. Autors Jorge Pérez López Codi 51250 PMID https://pubmed.ncbi.nlm.nih.gov/28847676 Nom Autors Belmatoug, Nadia; Bembi, Bruno; Deegan, Patrick; Di Rocco, Maja; Elstein, Deborah; Goker-Alpan, Ozlem; Hughes, Derralynn; Kuter, David J; Lukina, Elena; Mehta, Atul et al. DOI número 10.1016/j.ymgme.2017.08.002 Year 2017 Referencia Haematologica. 2017 Nov;102(11):e447-e451. doi: 10.3324/haematol.2017.168930. Epub 2017 Aug 24. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.3324/haematol.2017.168930 Revista HAEMATOLOGICA Títol Complet The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-kappaB mutational status. Codi 51249 PMID https://pubmed.ncbi.nlm.nih.gov/28838994 Nom Autors Bea, Silvia; Campo, Elias; Colomer, Dolors; Gine, Eva; Lee, Eriong; Lopez-Guerra, Monica; Lopez-Guillermo, Armando; Matas-Cespedes, Alba; Navarro, Alba; Perez-Galan, Patricia et al. DOI número 10.3324/haematol.2017.168930 Year 2017 Referencia Lung Cancer. 2017 Sep;111:143-149. doi: 10.1016/j.lungcan.2017.07.021. Epub 2017 Jul 22. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.lungcan.2017.07.021 Revista LUNG CANCER Títol Complet Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. Autors Irene Sansano Valero Codi 51248 PMID https://pubmed.ncbi.nlm.nih.gov/28838386 Nom Autors Bubendorf, Lukas; Cheney, Richard; Dafni, Urania; Das-Gupta, Ashis; Finn, Stephen P; Geiger, Thomas R; Hager, Henrik; Kammler, Roswitha; Kerr, Keith M; Marchetti, Antonio et al. DOI número 10.1016/j.lungcan.2017.07.021 Year 2017 Referencia Clin Breast Cancer. 2017 Dec;17(8):585-594.e4. doi: 10.1016/j.clbc.2017.05.006. Epub 2017 May 22. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.clbc.2017.05.006 Revista Clinical Breast Cancer Títol Complet RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer. Codi 51247 PMID https://pubmed.ncbi.nlm.nih.gov/28830796 Nom Autors Baselga, Jose; Bergh, Jonas; Bermejo, Begona; Chan, Arlene; Costa, Frederico; Gomez, Henry L; Gomez, Patricia; Gradishar, William J; Huang, Liping; Hudis, Clifford A et al. DOI número 10.1016/j.clbc.2017.05.006 Year 2017 Referencia J Clin Oncol. 2017 Oct 1;35(28):3198-3206. doi: 10.1200/JCO.2016.72.1076. Epub 2017 Aug 15. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1200/JCO.2016.72.1076 Revista JOURNAL OF CLINICAL ONCOLOGY Títol Complet Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m(2)) and the Currently Approved Dose (25 mg/m(2)) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA. Codi 51246 PMID https://pubmed.ncbi.nlm.nih.gov/28809610 Nom Autors Bernard, John; Carles, Joan; Chadjaa, Mustapha; de Bono, Johann; Eisenberger, Mario; Font, Albert; Ford, Daniel; Geczi, Lajos; Hardy-Bessard, Anne-Claire; Kacso, Gabriel et al. DOI número 10.1200/JCO.2016.72.1076 Year 2017 Referencia Lancet Oncol. 2017 Oct;18(10):1360-1372. doi: 10.1016/S1470-2045(17)30450-3. Epub 2017 Aug 8. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S1470-2045(17)30450-3 Revista LANCET ONCOLOGY Títol Complet Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Codi 51245 PMID https://pubmed.ncbi.nlm.nih.gov/28800861 Nom Autors Allison, Mary Ann K; Baselga, Jose; Bessard, Anne Hardy; Blau, Sibel; Blau, Sibel; Chan, David; Chan, Wai Y; Chen, Shin-Cheh; Chen, Yen-Hsun; Cobleigh, Melody et al. DOI número 10.1016/S1470-2045(17)30450-3 Year 2017 Referencia J Clin Oncol. 2017 Nov 1;35(31):3529-3537. doi: 10.1200/JCO.2017.73.3402. Epub 2017 Aug 10. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1200/JCO.2017.73.3402 Revista JOURNAL OF CLINICAL ONCOLOGY Títol Complet Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma. Codi 51244 PMID https://pubmed.ncbi.nlm.nih.gov/28796588 Nom Autors Abrisqueta, Pau; Belada, David; Burke, John M; Carella, Angelo Michele; Catalani, Olivier; Chua, Neil; Demeter, Judit; Fingerle-Rowson, Gunter; Flinn, Ian; Hong, Xiaonan et al. DOI número 10.1200/JCO.2017.73.3402 Year 2017 Referencia Sci Rep. 2017 Aug 9;7(1):7687. doi: 10.1038/s41598-017-08048-0. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/s41598-017-08048-0 Revista Scientific Reports Títol Complet Prognostic impact of CD133 expression in Endometrial Cancer Patients. Codi 51243 PMID https://pubmed.ncbi.nlm.nih.gov/28794448 Nom Autors Alameda, F; Aran, I; Carreras, R; Garrigos, L; Gibert, J; Lloveras, B; Lorenzo, M; Mancebo, G; Miralpeix, E; Mojal, S et al. DOI número 10.1038/s41598-017-08048-0 Year 2017 Referencia Br J Cancer. 2017 Sep 5;117(6):767-774. doi: 10.1038/bjc.2017.252. Epub 2017 Aug 8. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/bjc.2017.252 Revista BRITISH JOURNAL OF CANCER Títol Complet GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS). Codi 51242 PMID https://pubmed.ncbi.nlm.nih.gov/28787430 Nom Autors Castaneda, A; Cruz, J; Cruz, O; de Alava, E; de Torres, C; Garcia Del Muro, X; Lopez-Pousa, A; Maradiegue, E; Martin-Broto, J; Martinez-Trufero, J et al. DOI número 10.1038/bjc.2017.252 Year 2017 Referencia Oncologist. 2017 Sep;22(9):1049-1055. doi: 10.1634/theoncologist.2016-0178. Epub 2017 Aug 4. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1634/theoncologist.2016-0178 Revista ONCOLOGIST Títol Complet Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. Codi 51241 PMID https://pubmed.ncbi.nlm.nih.gov/28778958 Nom Autors Andersen, Rikke F; Boysen, Anders K; Brandslund, Ivan; Hansen, Torben F; Jakobsen, Anders; Jensen, Benny V; Johansen, Julia S; Pallisgard, Niels; Sefrioui, David; Sorensen, Morten M et al. DOI número 10.1634/theoncologist.2016-0178 Year 2017 Referencia Lancet. 2017 Oct 7;390(10103):1654-1663. doi: 10.1016/S0140-6736(17)31607-0. Epub 2017 Jul 27. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S0140-6736(17)31607-0 Revista LANCET Títol Complet Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Codi 51240 PMID https://pubmed.ncbi.nlm.nih.gov/28756902 Nom Autors Birrer, Michael J; Brady, Mark F; Burger, Robert A; Copeland, Larry J; Creasman, William T; DiSaia, Philip J; Huang, Helen; Koh, Wui-Jin; Landrum, Lisa M; Leitao, Mario M et al. DOI número 10.1016/S0140-6736(17)31607-0 Year 2017 Referencia Breast Cancer Res Treat. 2017 Nov;166(2):329-336. doi: 10.1007/s10549-017-4405-3. Epub 2017 Jul 28. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1007/s10549-017-4405-3 Revista BREAST CANCER RESEARCH AND TREATMENT Títol Complet Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients. Codi 51239 PMID https://pubmed.ncbi.nlm.nih.gov/28755147 Nom Autors Ahmed, Muneer; Baker, R; Benson, J; Douek, M; Jozsa, F; Rubio, I T et al. DOI número 10.1007/s10549-017-4405-3 Year 2017 Referencia Haematologica. 2017 Oct;102(10):1776-1784. doi: 10.3324/haematol.2017.164632. Epub 2017 Jul 27. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.3324/haematol.2017.164632 Revista HAEMATOLOGICA Títol Complet The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling. Codi 51238 PMID https://pubmed.ncbi.nlm.nih.gov/28751557 Nom Autors Blade, Joan; Calderon, Marcos; de Larrea, Carlos Fernandez; Diaz, Tania; Lozano, Ester; Martinez, Antonio; Mena, Mari-Pau; Perez-Galan, Patricia; Rodriguez, Vanina; Rosinol, Laura et al. DOI número 10.3324/haematol.2017.164632 Year 2017 Referencia Cancer Chemother Pharmacol. 2017 Sep;80(3):599-608. doi: 10.1007/s00280-017-3380-z. Epub 2017 Jul 25. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s00280-017-3380-z Revista CANCER CHEMOTHERAPY AND PHARMACOLOGY Títol Complet Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial. Codi 51237 PMID https://pubmed.ncbi.nlm.nih.gov/28744667 Nom Autors Bodoky, Gyorgy; Ciuleanu, Tudor; Clingan, Philip R; Cohn, Allen Lee; Ferry, David; Gao, Ling; Garcia-Alfonso, Pilar; Garcia-Carbonero, Rocio; Heinemann, Volker; Lonardi, Sara et al. DOI número 10.1007/s00280-017-3380-z Year 2017 Referencia Nature. 2017 Aug 3;548(7665):40-41. doi: 10.1038/nature23101. Epub 2017 Jul 19. Tipus publicació Editorail in international publication DOI http://dx.doi.org/10.1038/nature23101 Revista NATURE Títol Complet Cancer: A precision approach to tumour treatment. Codi 51234 PMID https://pubmed.ncbi.nlm.nih.gov/28723897 Nom Autors Dienstmann, Rodrigo; Tabernero, Josep et al. DOI número 10.1038/nature23101 Year 2017 Referencia Mol Cancer Ther. 2017 Oct;16(10):2215-2222. doi: 10.1158/1535-7163.MCT-16-0895. Epub 2017 Jul 17. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1158/1535-7163.MCT-16-0895 Revista MOLECULAR CANCER THERAPEUTICS Títol Complet Exposure-Response Analyses of Ramucirumab from Two Randomized, Phase III Trials of Second-line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer. Codi 51233 PMID https://pubmed.ncbi.nlm.nih.gov/28716815 Nom Autors Ajani, Jaffer A; Bodoky, Gyorgy; Chandrawansa, Kumari; Ferry, David; Fuchs, Charles S; Gao, Ling; Heathman, Michael; Hironaka, Shuichi; Hsu, Yanzhi; Khan, Azhar et al. DOI número 10.1158/1535-7163.MCT-16-0895 Year 2017 Referencia Case Rep Hematol. 2017;2017:4109605. doi: 10.1155/2017/4109605. Epub 2017 Jun 11. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.1155/2017/4109605 Revista Case reports in hematology Títol Complet Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain. Codi 51232 PMID https://pubmed.ncbi.nlm.nih.gov/28695025 Nom Autors Conill-Cortes, Clara; de Olivar-Oliver, Loreto; Grande-Garcia, Carlos; Mingot-Castellano, Maria-Eva; Valcarcel-Ferreiras, David et al. DOI número 10.1155/2017/4109605 Year 2017 Referencia Cancer Discov. 2017 Jul;7(7):666-669. doi: 10.1158/2159-8290.CD-17-0500. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.1158/2159-8290.CD-17-0500 Revista Cancer Discovery Títol Complet Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A New Light in the Darkness. Codi 51231 PMID https://pubmed.ncbi.nlm.nih.gov/28684409 Nom Autors Rodon, Jordi; Tabernero, Josep et al. DOI número 10.1158/2159-8290.CD-17-0500 Pagination First page « Previous page ‹ … Page 1949 Page 1950 Current page 1951 Page 1952 Page 1953 … Next page › Last page »
Year 2017 Referencia Eur Stroke J. 2017 Sep;2(3):229-237. doi: 10.1177/2396987317704547. Epub 2017 Apr 19. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1177/2396987317704547 Revista European stroke journal Títol Complet GISCOME - Genetics of Ischaemic Stroke Functional Outcome network: A protocol for an international multicentre genetic association study. Codi 51252 PMID https://pubmed.ncbi.nlm.nih.gov/31008316 Nom Autors Bevan, Steve; Fernandez-Cadenas, Israel; Hankey, Graeme J; Jern, Christina; Jimenez-Conde, Jordi; Jood, Katarina; Lee, Jin-Moo; Lemmens, Robin; Levi, Christopher; Lindgren, Arne et al. DOI número 10.1177/2396987317704547
Year 2017 Referencia Br J Cancer. 2017 Oct 24;117(9):1278-1285. doi: 10.1038/bjc.2017.290. Epub 2017 Aug 29. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/bjc.2017.290 Revista BRITISH JOURNAL OF CANCER Títol Complet Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib. Codi 51251 PMID https://pubmed.ncbi.nlm.nih.gov/28850565 Nom Autors Adenis, Antoine; Barone, Carlo; Bauer, Sebastian; Blay, Jean-Yves; Bouche, Olivier; Camozzi, Maura; Castellana, Ramon; Comandone, Alessandro; Crippa, Stefania; Del Muro, Xavier Garcia et al. DOI número 10.1038/bjc.2017.290
Year 2017 Referencia Mol Genet Metab. 2017 Nov;122(3):122-129. doi: 10.1016/j.ymgme.2017.08.002. Epub 2017 Aug 4. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.ymgme.2017.08.002 Revista MOLECULAR GENETICS AND METABOLISM Títol Complet Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians. Autors Jorge Pérez López Codi 51250 PMID https://pubmed.ncbi.nlm.nih.gov/28847676 Nom Autors Belmatoug, Nadia; Bembi, Bruno; Deegan, Patrick; Di Rocco, Maja; Elstein, Deborah; Goker-Alpan, Ozlem; Hughes, Derralynn; Kuter, David J; Lukina, Elena; Mehta, Atul et al. DOI número 10.1016/j.ymgme.2017.08.002
Year 2017 Referencia Haematologica. 2017 Nov;102(11):e447-e451. doi: 10.3324/haematol.2017.168930. Epub 2017 Aug 24. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.3324/haematol.2017.168930 Revista HAEMATOLOGICA Títol Complet The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-kappaB mutational status. Codi 51249 PMID https://pubmed.ncbi.nlm.nih.gov/28838994 Nom Autors Bea, Silvia; Campo, Elias; Colomer, Dolors; Gine, Eva; Lee, Eriong; Lopez-Guerra, Monica; Lopez-Guillermo, Armando; Matas-Cespedes, Alba; Navarro, Alba; Perez-Galan, Patricia et al. DOI número 10.3324/haematol.2017.168930
Year 2017 Referencia Lung Cancer. 2017 Sep;111:143-149. doi: 10.1016/j.lungcan.2017.07.021. Epub 2017 Jul 22. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.lungcan.2017.07.021 Revista LUNG CANCER Títol Complet Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. Autors Irene Sansano Valero Codi 51248 PMID https://pubmed.ncbi.nlm.nih.gov/28838386 Nom Autors Bubendorf, Lukas; Cheney, Richard; Dafni, Urania; Das-Gupta, Ashis; Finn, Stephen P; Geiger, Thomas R; Hager, Henrik; Kammler, Roswitha; Kerr, Keith M; Marchetti, Antonio et al. DOI número 10.1016/j.lungcan.2017.07.021
Year 2017 Referencia Clin Breast Cancer. 2017 Dec;17(8):585-594.e4. doi: 10.1016/j.clbc.2017.05.006. Epub 2017 May 22. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.clbc.2017.05.006 Revista Clinical Breast Cancer Títol Complet RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer. Codi 51247 PMID https://pubmed.ncbi.nlm.nih.gov/28830796 Nom Autors Baselga, Jose; Bergh, Jonas; Bermejo, Begona; Chan, Arlene; Costa, Frederico; Gomez, Henry L; Gomez, Patricia; Gradishar, William J; Huang, Liping; Hudis, Clifford A et al. DOI número 10.1016/j.clbc.2017.05.006
Year 2017 Referencia J Clin Oncol. 2017 Oct 1;35(28):3198-3206. doi: 10.1200/JCO.2016.72.1076. Epub 2017 Aug 15. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1200/JCO.2016.72.1076 Revista JOURNAL OF CLINICAL ONCOLOGY Títol Complet Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m(2)) and the Currently Approved Dose (25 mg/m(2)) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA. Codi 51246 PMID https://pubmed.ncbi.nlm.nih.gov/28809610 Nom Autors Bernard, John; Carles, Joan; Chadjaa, Mustapha; de Bono, Johann; Eisenberger, Mario; Font, Albert; Ford, Daniel; Geczi, Lajos; Hardy-Bessard, Anne-Claire; Kacso, Gabriel et al. DOI número 10.1200/JCO.2016.72.1076
Year 2017 Referencia Lancet Oncol. 2017 Oct;18(10):1360-1372. doi: 10.1016/S1470-2045(17)30450-3. Epub 2017 Aug 8. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S1470-2045(17)30450-3 Revista LANCET ONCOLOGY Títol Complet Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Codi 51245 PMID https://pubmed.ncbi.nlm.nih.gov/28800861 Nom Autors Allison, Mary Ann K; Baselga, Jose; Bessard, Anne Hardy; Blau, Sibel; Blau, Sibel; Chan, David; Chan, Wai Y; Chen, Shin-Cheh; Chen, Yen-Hsun; Cobleigh, Melody et al. DOI número 10.1016/S1470-2045(17)30450-3
Year 2017 Referencia J Clin Oncol. 2017 Nov 1;35(31):3529-3537. doi: 10.1200/JCO.2017.73.3402. Epub 2017 Aug 10. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1200/JCO.2017.73.3402 Revista JOURNAL OF CLINICAL ONCOLOGY Títol Complet Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma. Codi 51244 PMID https://pubmed.ncbi.nlm.nih.gov/28796588 Nom Autors Abrisqueta, Pau; Belada, David; Burke, John M; Carella, Angelo Michele; Catalani, Olivier; Chua, Neil; Demeter, Judit; Fingerle-Rowson, Gunter; Flinn, Ian; Hong, Xiaonan et al. DOI número 10.1200/JCO.2017.73.3402
Year 2017 Referencia Sci Rep. 2017 Aug 9;7(1):7687. doi: 10.1038/s41598-017-08048-0. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/s41598-017-08048-0 Revista Scientific Reports Títol Complet Prognostic impact of CD133 expression in Endometrial Cancer Patients. Codi 51243 PMID https://pubmed.ncbi.nlm.nih.gov/28794448 Nom Autors Alameda, F; Aran, I; Carreras, R; Garrigos, L; Gibert, J; Lloveras, B; Lorenzo, M; Mancebo, G; Miralpeix, E; Mojal, S et al. DOI número 10.1038/s41598-017-08048-0
Year 2017 Referencia Br J Cancer. 2017 Sep 5;117(6):767-774. doi: 10.1038/bjc.2017.252. Epub 2017 Aug 8. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/bjc.2017.252 Revista BRITISH JOURNAL OF CANCER Títol Complet GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS). Codi 51242 PMID https://pubmed.ncbi.nlm.nih.gov/28787430 Nom Autors Castaneda, A; Cruz, J; Cruz, O; de Alava, E; de Torres, C; Garcia Del Muro, X; Lopez-Pousa, A; Maradiegue, E; Martin-Broto, J; Martinez-Trufero, J et al. DOI número 10.1038/bjc.2017.252
Year 2017 Referencia Oncologist. 2017 Sep;22(9):1049-1055. doi: 10.1634/theoncologist.2016-0178. Epub 2017 Aug 4. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1634/theoncologist.2016-0178 Revista ONCOLOGIST Títol Complet Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. Codi 51241 PMID https://pubmed.ncbi.nlm.nih.gov/28778958 Nom Autors Andersen, Rikke F; Boysen, Anders K; Brandslund, Ivan; Hansen, Torben F; Jakobsen, Anders; Jensen, Benny V; Johansen, Julia S; Pallisgard, Niels; Sefrioui, David; Sorensen, Morten M et al. DOI número 10.1634/theoncologist.2016-0178
Year 2017 Referencia Lancet. 2017 Oct 7;390(10103):1654-1663. doi: 10.1016/S0140-6736(17)31607-0. Epub 2017 Jul 27. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S0140-6736(17)31607-0 Revista LANCET Títol Complet Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Codi 51240 PMID https://pubmed.ncbi.nlm.nih.gov/28756902 Nom Autors Birrer, Michael J; Brady, Mark F; Burger, Robert A; Copeland, Larry J; Creasman, William T; DiSaia, Philip J; Huang, Helen; Koh, Wui-Jin; Landrum, Lisa M; Leitao, Mario M et al. DOI número 10.1016/S0140-6736(17)31607-0
Year 2017 Referencia Breast Cancer Res Treat. 2017 Nov;166(2):329-336. doi: 10.1007/s10549-017-4405-3. Epub 2017 Jul 28. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1007/s10549-017-4405-3 Revista BREAST CANCER RESEARCH AND TREATMENT Títol Complet Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients. Codi 51239 PMID https://pubmed.ncbi.nlm.nih.gov/28755147 Nom Autors Ahmed, Muneer; Baker, R; Benson, J; Douek, M; Jozsa, F; Rubio, I T et al. DOI número 10.1007/s10549-017-4405-3
Year 2017 Referencia Haematologica. 2017 Oct;102(10):1776-1784. doi: 10.3324/haematol.2017.164632. Epub 2017 Jul 27. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.3324/haematol.2017.164632 Revista HAEMATOLOGICA Títol Complet The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling. Codi 51238 PMID https://pubmed.ncbi.nlm.nih.gov/28751557 Nom Autors Blade, Joan; Calderon, Marcos; de Larrea, Carlos Fernandez; Diaz, Tania; Lozano, Ester; Martinez, Antonio; Mena, Mari-Pau; Perez-Galan, Patricia; Rodriguez, Vanina; Rosinol, Laura et al. DOI número 10.3324/haematol.2017.164632
Year 2017 Referencia Cancer Chemother Pharmacol. 2017 Sep;80(3):599-608. doi: 10.1007/s00280-017-3380-z. Epub 2017 Jul 25. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s00280-017-3380-z Revista CANCER CHEMOTHERAPY AND PHARMACOLOGY Títol Complet Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial. Codi 51237 PMID https://pubmed.ncbi.nlm.nih.gov/28744667 Nom Autors Bodoky, Gyorgy; Ciuleanu, Tudor; Clingan, Philip R; Cohn, Allen Lee; Ferry, David; Gao, Ling; Garcia-Alfonso, Pilar; Garcia-Carbonero, Rocio; Heinemann, Volker; Lonardi, Sara et al. DOI número 10.1007/s00280-017-3380-z
Year 2017 Referencia Nature. 2017 Aug 3;548(7665):40-41. doi: 10.1038/nature23101. Epub 2017 Jul 19. Tipus publicació Editorail in international publication DOI http://dx.doi.org/10.1038/nature23101 Revista NATURE Títol Complet Cancer: A precision approach to tumour treatment. Codi 51234 PMID https://pubmed.ncbi.nlm.nih.gov/28723897 Nom Autors Dienstmann, Rodrigo; Tabernero, Josep et al. DOI número 10.1038/nature23101
Year 2017 Referencia Mol Cancer Ther. 2017 Oct;16(10):2215-2222. doi: 10.1158/1535-7163.MCT-16-0895. Epub 2017 Jul 17. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1158/1535-7163.MCT-16-0895 Revista MOLECULAR CANCER THERAPEUTICS Títol Complet Exposure-Response Analyses of Ramucirumab from Two Randomized, Phase III Trials of Second-line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer. Codi 51233 PMID https://pubmed.ncbi.nlm.nih.gov/28716815 Nom Autors Ajani, Jaffer A; Bodoky, Gyorgy; Chandrawansa, Kumari; Ferry, David; Fuchs, Charles S; Gao, Ling; Heathman, Michael; Hironaka, Shuichi; Hsu, Yanzhi; Khan, Azhar et al. DOI número 10.1158/1535-7163.MCT-16-0895
Year 2017 Referencia Case Rep Hematol. 2017;2017:4109605. doi: 10.1155/2017/4109605. Epub 2017 Jun 11. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.1155/2017/4109605 Revista Case reports in hematology Títol Complet Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain. Codi 51232 PMID https://pubmed.ncbi.nlm.nih.gov/28695025 Nom Autors Conill-Cortes, Clara; de Olivar-Oliver, Loreto; Grande-Garcia, Carlos; Mingot-Castellano, Maria-Eva; Valcarcel-Ferreiras, David et al. DOI número 10.1155/2017/4109605
Year 2017 Referencia Cancer Discov. 2017 Jul;7(7):666-669. doi: 10.1158/2159-8290.CD-17-0500. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.1158/2159-8290.CD-17-0500 Revista Cancer Discovery Títol Complet Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A New Light in the Darkness. Codi 51231 PMID https://pubmed.ncbi.nlm.nih.gov/28684409 Nom Autors Rodon, Jordi; Tabernero, Josep et al. DOI número 10.1158/2159-8290.CD-17-0500
